Treatment of light chain deposition disease with bortezomib and dexamethasone
Letter 2008 en
Authors
EK
Efstathios Kastritis
MM
Magdalini Migkou
MG
Maria Gavriatopoulou
Abstract
1 min read
Light chain deposition disease (LCDD) is a rare plasma cell dyscrasia characterized by deposition of immunoglobulin fragments. The kidneys are almost always affected while heart, liver and other tissues are occasionally involved. About 50% of patients with LCDD have concurrent myeloma, however most
Efstathios Kastritis, Athanasios K. Anagnostopoulos, Μαρία Ρούσσου, Savvas Toumanidis, Constantinos Pamboukas, Anna Tassidou, Irini Xilouri, Sossana Delimpassi, Erasmia Psimenou, S. Mellou, Evangelos Terpos, John N. Nanas, Meletios A Dimopoulos
Discussion(0)
No comments yet. Be the first to comment.